skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Estrogen depletion alters osteogenic differentiation and matrix production by osteoblasts in vitro

Journal Article · · Experimental Cell Research
 [1];  [1];
  1. Mechanobiology and Medical Device Research Group (MMDRG), Biomechanics Research Centre (BMEC), Biomedical Engineering, College of Engineering and Informatics, National University of Ireland Galway, Galway (Ireland)

Highlights: • Estrogen depletion accelerates osteoblast differentiation in static culture. • Mechanical stimulation exacerbated the effects of estrogen depletion on osteoblast differentiation. • Estrogen depletion alters osteoblasts capacity to produce a good quality matrix. Recent studies have revealed that the effects of estrogen deficiency are not restricted to osteoclasts and bone resorption, but that bone matrix composition is altered and osteoblasts exhibit an impaired response to mechanical stimulation. In this study, we test the hypothesis that estrogen depletion alters osteogenic differentiation and matrix production by mechanically stimulated osteoblasts in vitro. MC3T3-E1 cells were pre-treated with estrogen for 14 days, after which estrogen was withdrawn or inhibited with Fulvestrant up to 14 days. Fluid shear stress (FSS) was applied using an orbital shaker. Under estrogen depletion in static culture, osteogenic marker (ALP) and gene expression (Runx2) were decreased at 2 and after 7 days of estrogen depletion, respectively. In addition, up to 7 day the inhibition of the estrogen receptor significantly decreased fibronectin expression (FN1) under static conditions. Under estrogen depletion and daily mechanical stimulation, changes in expression of Runx2 occurred earlier (4 days) and by 14 days, changes in matrix production (Col1a1) were reported. We propose that changes in osteoblast differentiation and impaired matrix production during estrogen depletion may contribute to the altered quality of the bone and act as a contributing factor to increased bone fragility in postmenopausal osteoporosis.

OSTI ID:
23195462
Journal Information:
Experimental Cell Research, Vol. 408, Issue 1; Other Information: Copyright (c) 2021 The Authors. Published by Elsevier Inc.; Country of input: International Atomic Energy Agency (IAEA); ISSN 0014-4827
Country of Publication:
United States
Language:
English

Similar Records

Impaired osteoblast differentiation in Annexin A2- and -A5-deficient cells
Journal Article · Mon Sep 15 00:00:00 EDT 2014 · PLoS One, 9(9):Article No. e107482 · OSTI ID:23195462

Acerogenin A, a natural compound isolated from Acer nikoense Maxim, stimulates osteoblast differentiation through bone morphogenetic protein action
Journal Article · Fri Mar 11 00:00:00 EST 2011 · Biochemical and Biophysical Research Communications · OSTI ID:23195462

Identification of Rorβ targets in cultured osteoblasts and in human bone
Journal Article · Fri Nov 01 00:00:00 EDT 2013 · Biochemical and Biophysical Research Communications · OSTI ID:23195462